Consequently, inhibition of MAGL has anti-inflammatory and neuroprotective effects in animal models of Parkinson’s and Alzheimer’s disease by interfering with eicosanoid rather than cannabinoid signaling [36, 37]. The gene discussed is MGLL; the disease is Parkinsonism.